Article
Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells.
Molecular and cellular biochemistry - 1 Nov 2011
Li Jian, Zhang Yangde, Zhao Jingfeng, Kong Fangren, Chen Yuxiang
Abstract excerpt
Chemoresistance is a key cause of treatment failure in colon cancer. MiR-22 is a tumor-suppressing microRNA. To explore whether miR-22 is an important player in the development of chemoresistance in colon cancer, we overexpressed miR-22 and subsequently tested its role in cell proliferation, apoptosis, survival, and associated signaling in p53-mutated HT-29 and HCT-15 cells, and p53 wild-type HCT-116 cells. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
